GlassScriptPhysician profile
James J Perez
NPI 1073543500
$834.10
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $43.40 · 2021: $27.72 · 2022: $169 · 2023: $45.78 · 2024: $60.07 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.11 | 2019-2022 | |
| Gynesonics, INC. | $156.17 | 2022 | |
| Hologic Sales and Service, LLC | $122.29 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medical Device Business Services, INC. | $111.68 | 2019 | |
| Minerva Surgical, INC | $77.18 | 2019 | |
| Ge Healthcare | $60.07 | 2024 | |
| Smith+Nephew, INC. | $45.78 | 2023 | Pico 7 |
| Allergan, INC. | $43.40 | 2020 | |
| Ethicon US, LLC | $30.76 | 2019 | |
| Astellas Pharma Global Development | $16.66 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.